Stuck on meds: Some can't quit antidepressants
Syndrome makes it impossible for some patients to wean off medication
Associated Press
Aug 7, 2006

When Gina O’Brien decided she no longer needed drugs to quell her anxiety and panic attacks, she followed doctor’s orders by slowly tapering her dose of the antidepressant Paxil.

The gradual withdrawal was supposed to prevent unpleasant symptoms that can result from stopping antidepressants cold turkey. But it didn’t work.

“I felt so sick that I couldn’t get off my couch,” O’Brien said. “I couldn’t stop crying.”

Overwhelmed by nausea and uncontrollable crying, she felt she had no choice but to start taking the pills again. More than a year later she still takes Paxil, and expects to be on it for the rest of her life.

In the almost two decades since Prozac — the first of the antidepressants known as SRIs, or serotonin reuptake inhibitors — hit the market, many patients have reported extreme reactions to discontinuing the drugs. Two of the best-selling antidepressants — Effexor and Paxil — have prompted so many complaints that many doctors avoid prescribing them altogether.

“It’s not that we never use it, but in the end I will tend not to prescribe Effexor or Paxil,” said Dr. Richard C. Shelton, a psychiatrist at the Vanderbilt University School of Medicine.

Patients report experiencing all sorts of symptoms, sometimes within hours of stopping their medication. They can suffer from flu-like nausea, muscle aches, uncontrollable crying, dizziness and diarrhea. Many patients suffer “brain zaps,” bizarre and briefly overwhelming electrical sensations that propagate from the back of the head.

“It’s almost like pins and needles, and jittery on the inside,” said a New York children’s entertainer who asked that his name be withheld to protect his professional reputation.

Though not exactly painful, they are briefly disorienting and can be terrifying to patients who don’t know what they are experiencing. There are case reports of people who have just quit antidepressants showing up in hospital emergency rooms, thinking they are suffering from seizures.

Toni Wilson certainly didn’t know how unpleasant going off Zoloft could be when her doctor recently switched her to Wellbutrin, telling her that the new drug would “take the place of” the old one. The two antidepressants actually work on entirely different neurochemical systems, so going straight from one to the other was equivalent to quitting Zoloft cold turkey.

“After about three days I felt real anxious and irritable,” Wilson said in an e-mail message. “I would shake, not eat much, it felt like little needles in my body and head.”

After two weeks, Wilson said, she was rescued from the brink of suicide by a friend who recognized the severity of the situation and took her to the hospital. That was where she learned what had happened to her.

Few doctors know enough about weaning

Cases like Wilson’s would be virtually nonexistent if physicians took more care in weaning their patients off antidepressants, said Philip Ninan, vice president for neuroscience at Wyeth, the maker of Effexor.

“The management of discontinuation symptoms is relatively easy if you know about it,” Ninan said, and noted that Wyeth had made efforts to educate both physicians and patients.

Yet surprisingly few doctors know enough about SRI discontinuation to manage it effectively. A 1997 survey of English doctors found that 28 percent of psychiatrists and 70 percent of general practitioners had no idea that patients might have problems after discontinuing antidepressants. Awareness may have increased since then, but the phenomenon is so little studied that no one has done the necessary research to find out.

Impacts more than mood

So little is known about it that researchers aren’t even exactly sure what causes antidepressant discontinuation syndrome. It must be related to the fact that the brain chemical affected by most of the antidepressants on the market today, serotonin, does a lot more than regulate mood. It is also involved in sleep, balance, digestion and other physiological processes. So when you throw the brain’s serotonin system out of whack, which is essentially what you’re doing by either starting or discontinuing an antidepressant, virtually the whole body can be affected.

Generally the drugs that are metabolized most quickly cause more severe symptoms, Shelton said. Effexor, with a half-life of just a few hours, is one of the worst SRIs in that regard; Prozac, which has a half-life of about a week, is considered the best.

Not hard for everyone

“I don’t think they’re difficult to go off,” said Alan Schatzberg, chairman of the department of psychiatry and behavioral sciences at the Stanford University School of Medicine. “The vast majority of people aren’t that sensitive.”

Schatzberg recently chaired a Wyeth-sponsored panel of physicians that offered guidelines for how to manage “antidepressant discontinuation syndrome,” the preferred medical term for what a layperson would think of as withdrawal.

Terms like “antidepressant discontinuation syndrome” demonstrate the pharmaceutical industry’s efforts to downplay the problem, charged Karen Menzies, an attorney who has been involved in litigation over the phenomenon.

“Withdrawal is the word that is used in Europe,” she said.

Feels like withdrawl

But drug companies insist antidepressants can’t cause withdrawal because they are not technically addictive. Even so, many patients who have gone through the experience say it feels like withdrawal to them. Some can’t work, drive, socialize or do other everyday things for weeks.

“You just feel awful,” said the children’s entertainer, who has taken a small dose of Effexor for eight years rather than suffer through the withdrawal experience. But he said the inconvenience is worth it for the benefits the drug provided him when he did need it.

Taking SRIs indefinitely is not an attractive option for many patients because it means putting up with unpleasant side-effects such as weight gain and sexual dysfunction. For women who want to have children it’s an especially risky choice; researchers have documented withdrawal in newborns whose mothers were taking antidepressants, and some SRIs have been linked to birth defects.

Having to keep taking Paxil makes O’Brien angry because she feels at the mercy of GlaxoSmithKline, the company that makes it.